Relugolix–estradiol–norethisterone acetate
Amber level 0
Brand:
Ryeqo
Nice TA:
832
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
1.1 Relugolix–estradiol–norethisterone acetate is recommended, within its
marketing authorisation, as an option for treating moderate to severe
symptoms of uterine fibroids in adults of reproductive age.
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: